{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Study+sample+collection&page=26", "query": { "intervention": "Study sample collection", "page": 26 }, "page_size": 10 }, "pagination": { "page": 26, "page_size": 10, "total_count": 2549, "total_pages": 255, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Study+sample+collection&page=27&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Study+sample+collection&page=25&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-21T22:52:47.407Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06369610", "title": "Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Oligometastatic Prostate Carcinoma", "Prostate Adenocarcinoma" ], "interventions": [ { "name": "Abiraterone Acetate", "type": "DRUG" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Gonadotropin-releasing Hormone Analog", "type": "BIOLOGICAL" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Radiation Therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "PROCEDURE", "BIOLOGICAL", "OTHER", "RADIATION" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 110, "start_date": "2024-04-22", "completion_date": "2028-07-29", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-10-21T22:52:47.407Z", "location_count": 1, "location_summary": "Scottsdale, Arizona", "locations": [ { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06369610" }, { "nct_id": "NCT01227018", "title": "PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Adenocarcinoma of the Pancreas", "Recurrent Pancreatic Cancer", "Stage IV Pancreatic Cancer" ], "interventions": [ { "name": "STA-9090", "type": "DRUG" }, { "name": "Radiologic imaging", "type": "RADIATION" }, { "name": "blood draw", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "RADIATION", "PROCEDURE" ], "sponsor": "Vanderbilt-Ingram Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2010-12", "completion_date": "2013-05", "has_results": true, "last_update_posted_date": "2014-07-23", "last_synced_at": "2026-10-21T22:52:47.407Z", "location_count": 2, "location_summary": "Memphis, Tennessee • Nashville, Tennessee", "locations": [ { "city": "Memphis", "state": "Tennessee" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01227018" }, { "nct_id": "NCT03895320", "title": "Protecting Our Future Generation: Promotion of Protective Sexual Health Practices Among Native American Youth and Young Adults Through an Assets-based Self-care Intervention", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Sexual Behavior", "Unprotected Sex", "Gonorrhea", "Chlamydia", "Trichomonas", "Sexually Transmitted Diseases", "Adolescent Behavior", "Self Evaluation" ], "interventions": [ { "name": "Sexual Health Risk Assessment", "type": "BEHAVIORAL" }, { "name": "Sexual Health Score", "type": "BEHAVIORAL" }, { "name": "Sexual Health Messaging", "type": "BEHAVIORAL" }, { "name": "Water SSB Quiz", "type": "BEHAVIORAL" }, { "name": "Water SSB Score", "type": "BEHAVIORAL" }, { "name": "Water SSB Messaging", "type": "BEHAVIORAL" }, { "name": "STI Screening", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Johns Hopkins Bloomberg School of Public Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "14 Years", "maximum_age": "26 Years", "sex": "ALL", "summary": "14 Years to 26 Years" }, "enrollment_count": 219, "start_date": "2019-03-01", "completion_date": "2022-03-31", "has_results": false, "last_update_posted_date": "2024-02-23", "last_synced_at": "2026-10-21T22:52:47.407Z", "location_count": 1, "location_summary": "Whiteriver, Arizona", "locations": [ { "city": "Whiteriver", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT03895320" }, { "nct_id": "NCT06686043", "title": "HPV Vaccine, Imiquimod, and Metformin Combination Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cervical Carcinoma", "Vaginal Carcinoma", "Vulvar Carcinoma", "HPV (Human Papillomavirus)-Associated Carcinoma" ], "interventions": [ { "name": "HPV vaccine, Imiquimod, and metformin combination therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "FEMALE", "summary": "18 Years to 64 Years · Female only" }, "enrollment_count": 85, "start_date": "2024-08-23", "completion_date": "2028-08-23", "has_results": false, "last_update_posted_date": "2024-11-13", "last_synced_at": "2026-10-21T22:52:47.407Z", "location_count": 2, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06686043" }, { "nct_id": "NCT07169617", "title": "Testing the SurVaxM Vaccine for Lung Cancer Prevention", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lung Carcinoma" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Montanide ISA 51 VG", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Sargramostim", "type": "BIOLOGICAL" }, { "name": "SVN53-67/M57-KLH Peptide Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER", "BIOLOGICAL" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2026-10-01", "completion_date": "2029-12-31", "has_results": false, "last_update_posted_date": "2026-08-26", "last_synced_at": "2026-10-21T22:52:47.407Z", "location_count": 4, "location_summary": "Aurora, Colorado • Chicago, Illinois • Buffalo, New York + 1 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Buffalo", "state": "New York" }, { "city": "Knoxville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT07169617" }, { "nct_id": "NCT06734117", "title": "A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Acute Coronary Syndrome", "Myocardial Infarction" ], "interventions": [ { "name": "Elecsys® Troponin T hs Gen 6", "type": "DIAGNOSTIC_TEST" }, { "name": "Blood sample collection", "type": "PROCEDURE" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "PROCEDURE" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "20 Years", "maximum_age": null, "sex": "ALL", "summary": "20 Years and older" }, "enrollment_count": 5429, "start_date": "2021-11-15", "completion_date": "2024-12-26", "has_results": false, "last_update_posted_date": "2025-01-24", "last_synced_at": "2026-10-21T22:52:47.407Z", "location_count": 26, "location_summary": "El Centro, California • La Jolla, California • Gainesville, Florida + 21 more", "locations": [ { "city": "El Centro", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Fort Wayne", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT06734117" }, { "nct_id": "NCT00918658", "title": "Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Leukemia", "Multiple Myeloma and Plasma Cell Neoplasm" ], "interventions": [ { "name": "biologic sample preservation procedure", "type": "OTHER" }, { "name": "immunologic technique", "type": "OTHER" }, { "name": "laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Case Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 34, "start_date": "2008-04", "completion_date": "2011-03", "has_results": false, "last_update_posted_date": "2015-10-09", "last_synced_at": "2026-10-21T22:52:47.407Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00918658" }, { "nct_id": "NCT01209585", "title": "A Study to Evaluate BioMarkers in Blood Samples in Subjects With Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Arthritis" ], "interventions": [ { "name": "Blood samples", "type": "OTHER" }, { "name": "Synovial fluid aspiration", "type": "OTHER" }, { "name": "Synovial tissue sample", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "MedImmune LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 23, "start_date": "2011-03", "completion_date": "2013-03", "has_results": false, "last_update_posted_date": "2013-07-25", "last_synced_at": "2026-10-21T22:52:47.407Z", "location_count": 3, "location_summary": "Frederick, Maryland • Wyomissing, Pennsylvania • Jackson, Tennessee", "locations": [ { "city": "Frederick", "state": "Maryland" }, { "city": "Wyomissing", "state": "Pennsylvania" }, { "city": "Jackson", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01209585" }, { "nct_id": "NCT06640010", "title": "Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hematopoietic and Lymphatic System Neoplasm", "Malignant Solid Neoplasm" ], "interventions": [ { "name": "Non-Interventional Study", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2025-02-12", "completion_date": "2027-12-15", "has_results": false, "last_update_posted_date": "2026-06-23", "last_synced_at": "2026-10-21T22:52:47.407Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06640010" }, { "nct_id": "NCT07740291", "title": "Tirzepatide Impact Assessment Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity & Overweight", "Cardiometabolic Health Indicators", "Addiction", "Eating Disorders", "Mental Health" ], "interventions": [ { "name": "GLP-1 Receptor Agonist Therapy", "type": "DRUG" }, { "name": "Structured Lifestyle Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "Texas Tech University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27, "start_date": "2025-01-02", "completion_date": "2026-12-07", "has_results": false, "last_update_posted_date": "2026-07-31", "last_synced_at": "2026-10-21T22:52:47.407Z", "location_count": 1, "location_summary": "Lubbock, Texas", "locations": [ { "city": "Lubbock", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07740291" } ] }